Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Tedford

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1994
Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomesT R Tephly, B Coffman, P Styczynski, et al.
European Journal of Pharmacology|August 28, 1998
High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional modelsC E Tedford, M Hoffmann, N Seyedi, et al.
Psychopharmacology|January 1, 1993
Determination of plasma and brain concentrations of SCH 39166 and their correlation to conditioned avoidance behavior in ratsC E Tedford, V L Coffin, V Ruperto, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligandsS L Yates, J G Phillips, R Gregory, et al.
Drug and Alcohol Dependence|June 10, 2006
Nullifying drug-induced sensitization: behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized ratsJ McDaid, C E Tedford, A R Mackie, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Development of trans-2-[1H-imidazol-4-yl] cyclopropane derivatives as new high-affinity histamine H3 receptor ligandsC E Tedford, J G Phillips, R Gregory, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Pharmacological characterization of GT-2016, a non-thiourea-containing histamine H3 receptor antagonist: in vitro and in vivo studiesC E Tedford, S L Yates, G P Pawlowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2011
Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injuryWilhelm J Schwaeble, Nicholas J Lynch, James E Clark, et al.
Personality Disorders|April 14, 2015
Choice impulsivity: Definitions, measurement issues, and clinical implicationsKristen R Hamilton, Marci R Mitchell, Victoria C Wing, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1994
Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomesT R Tephly, B Coffman, P Styczynski, et al.
European Journal of Pharmacology|August 28, 1998
High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional modelsC E Tedford, M Hoffmann, N Seyedi, et al.
Psychopharmacology|January 1, 1993
Determination of plasma and brain concentrations of SCH 39166 and their correlation to conditioned avoidance behavior in ratsC E Tedford, V L Coffin, V Ruperto, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligandsS L Yates, J G Phillips, R Gregory, et al.
Drug and Alcohol Dependence|June 10, 2006
Nullifying drug-induced sensitization: behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized ratsJ McDaid, C E Tedford, A R Mackie, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Development of trans-2-[1H-imidazol-4-yl] cyclopropane derivatives as new high-affinity histamine H3 receptor ligandsC E Tedford, J G Phillips, R Gregory, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Pharmacological characterization of GT-2016, a non-thiourea-containing histamine H3 receptor antagonist: in vitro and in vivo studiesC E Tedford, S L Yates, G P Pawlowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2011
Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injuryWilhelm J Schwaeble, Nicholas J Lynch, James E Clark, et al.
Personality Disorders|April 14, 2015
Choice impulsivity: Definitions, measurement issues, and clinical implicationsKristen R Hamilton, Marci R Mitchell, Victoria C Wing, et al.
Pageof 5